Invacare Corporation to Present at the 20th Annual CJS Securities New Ideas Summer Conference

ELYRIA, Ohio–(BUSINESS WIRE)– Invacare Corporation (NYSE:IVC)(the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matthew E. Monaghan, chairman, president and chief executive officer will present at the 20th Annual New Ideas Summer Conference on Tuesday, July 14, 2020. In addition, the Company will be available to host 1×1 investor meetings.

A copy of the updated IR presentation will be posted on the Company’s website at newsroom.invacare.com.

About Invacare Corporation

Invacare Corporation (NYSE: IVC) is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), age-related, bariatric) ailments. The company’s products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, dealers and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare’s website at www.invacare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005848/en/

Source: Invacare Corporation

Previous Post
Invacare Corporation Completes Private Exchange to Retire Approximately $35 Million Principal Amount of Its 5.0% Convertible Senior Notes Due 2021 and Approximately $39 Million Principal Amount of Its 4.5% Convertible Senior Notes Due 2022
Next Post
Invacare Corporation Announces Preliminary Financial Results for 2Q20 and Provides Business Update